Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
CC transcript
Quarterly results
Appointed director
|
|
Viracta Therapeutics, Inc. (VIRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/05/2023 |
8-K/A
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"8-K/A",
"CONSULTING AGREEMENT This consulting agreement is made by and between VIRACTA THERAPEUTICS, INC., having a place of business at 2533 South Coast Hwy 101, Suite 210, Cardiff, CA 92007 USA, together with its affiliates and Lisa Rojkjaer, M.D., an individual with a place of business at [***] , effective on the 5th day of May, 2023 at 4:59pm PDT for the purpose of setting forth the exclusive terms and conditions by which Company will acquire Consultant's services on a temporary basis. 1. WORK AND PAYMENT. Attached to this Agreement as is a project assignment describing the work Consultant will perform . This Project Assignment, and any future Project Assignment, will be subject to the terms and conditions of this Agreement and will set forth at a minimum the following terms: Consultant's rate ..." |
|
| 03/23/2021 |
8-K/A
| Quarterly results |
|
|